Misra Tushar

SVP, Chief Manuf. Officer at Mersana Therapeutics, Inc.

Sold, on record
$27k
Dollars the filings state
Form 4 sales
4
Latest Jan 16, 2024
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Mersana Therapeutics, Inc.Unusual
    Aug 17, 2022 2022

    Sold 1,879 shares at $7.10 ($13k)

    Misra Tushar, Chief Manufacturing Officer

    Sold 30.1% of holdings ($44k position)4,371 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Mersana Therapeutics, Inc.Plan not stated
    Jan 17, 2023 +153 days

    Sold 458 shares at $5.74 ($3k)

    Misra Tushar, SVP, CMO

    Sold 7.2% of holdings ($37k position)5,930 shares leftFiling

  3. 3 Form 4 sale Mersana Therapeutics, Inc.Routine
    Aug 17, 2023 +212 days

    Sold 1,908 shares at $1.18 ($2k)

    Misra Tushar, SVP, Chief Manuf. Officer

    10b5-1 planSold 14.2% of holdings ($16k position)11,507 shares leftFiling

  4. 4 Form 4 sale Mersana Therapeutics, Inc.Routine
    Jan 16, 2024 +152 days

    Sold 3,357 shares at $2.71 ($9k)

    Misra Tushar, SVP, Chief Manuf. Officer

    10b5-1 planSold 15.7% of holdings ($58k position)17,966 shares left1.8x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Misra Tushar
Source
Jan 16, 2024Jan 17, 2024Mersana Therapeutics, Inc.SVP, Chief Manuf. OfficerForm 4 sale3,357$9k15.7%RoutineSEC
Aug 17, 2023Aug 18, 2023Mersana Therapeutics, Inc.SVP, Chief Manuf. OfficerForm 4 sale1,908$2k14.2%RoutineSEC
Jan 17, 2023Jan 18, 2023Mersana Therapeutics, Inc.SVP, CMOForm 4 sale458$3k7.2%Plan not statedSEC
Aug 17, 2022Aug 18, 2022Mersana Therapeutics, Inc.Chief Manufacturing OfficerForm 4 sale1,879$13k30.1%UnusualSEC